Cargando…
Neuroendocrine Carcinomas of the Digestive Tract: What Is New?
SIMPLE SUMMARY: In this narrative review, we describe the current data and management of neuroendocrine carcinomas (NEC) of the digestive tract. These tumors are very rare and suffer from a lack of clinical trials which would allow for standardized therapeutic management. To date, most guidelines co...
Autores principales: | Pellat, Anna, Cottereau, Anne Ségolène, Terris, Benoit, Coriat, Romain |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345167/ https://www.ncbi.nlm.nih.gov/pubmed/34359666 http://dx.doi.org/10.3390/cancers13153766 |
Ejemplares similares
-
Digestive Well-Differentiated Grade 3 Neuroendocrine Tumors: Current Management and Future Directions
por: Pellat, Anna, et al.
Publicado: (2021) -
Well Differentiated Grade 3 Neuroendocrine Tumors of the Digestive Tract: A Narrative Review
por: Pellat, Anna, et al.
Publicado: (2020) -
Medical Treatment of Advanced Pancreatic Neuroendocrine Neoplasms
por: Palmieri, Lola-Jade, et al.
Publicado: (2020) -
Indications of Peptide Receptor Radionuclide Therapy (PRRT) in Gastroenteropancreatic and Pulmonary Neuroendocrine Tumors: An Updated Review
por: Camus, Baptiste, et al.
Publicado: (2021) -
Airborne transmission of SARS‐Cov2: What consequences for digestive endoscopy?
por: Chaussade, Stanislas, et al.
Publicado: (2023)